Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
25 participants
INTERVENTIONAL
2023-05-01
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
UPnRIDE Power Standing Wheelchair for SCI
NCT04163796
Effects of In-Wheel Suspension
NCT04467749
Powered Exoskeletons in Persons With SCI
NCT02658656
Multi-speed Ergonomic Wheelchair
NCT05776030
Supportive Wheelchair Back Compared to Fabric Back
NCT03962582
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research Questions (Objectives) - The purpose of this project is to extend testing of the MMSW to home and community environments of 48 Veterans with SCI to see if mobility in standing affects utility and standing time.
Relevance to VA - There is a mounting body of literature showing significant adverse health consequences associated with excessive time spent in a seated position. Any person who has an underlying condition which impairs their ability to stand or walk is at increased risk for seating related adverse health consequences. There are an estimated 1.7 million people in the United States who have enough impairment that they use seated mobility devices (wheelchairs and scooters). Specifically, people with spinal cord injuries (SCI) are particularly prone to complications from excessive sitting, because many are unable to stand without some type of support. According to the VA's Corporate Data Warehouse, the VA provides care to 17,886 Veterans with SCI/D each year and estimate that over 7,000 of these Veterans have paraplegia. Excessive sitting after SCI is believed to contribute to pressure injuries, worsening pain, osteoporosis, joint stiffness, spasticity, and worsening bowel and bladder function. Until recently, there have been few practical options for safely supporting these individuals while standing or walking. Although there is now a growing list of assistive devices available to support standing and walking in SCI, relatively little attention has been given to determining how often such devices are used or how often they would need to be used to optimally promote the various potential health-related outcomes, nor which devices are most likely to achieve these changes.
Number of Research Participants (Sample Size) - Forty-eight participants (24/group) will be randomized. Each of the two study sites will be expected to screen up to 390 participants to reach the target of 48 randomized over both sites.
Participating Sites - Minneapolis VA Health Care System, VA Palo Alto Health Care System
Duration of Participant Intake (Study Duration) - This project is projected to be a total of four years. The two study sites will have a start-up period of between three to six months and will recruit for approximately three years. The remaining six to nine months will be used for dissemination of study results and study close-out.
Treatment (follow-up) - The intervention being tested is two months of home and community use of a manual standing wheelchair (mobile or non-mobile in standing).
Endpoints - The primary outcomes for this study are utility and standing dose.
Utility - The utility of the study wheelchairs and the current standing device (when applicable) will be assessed using the Wheelchair Outcome Measure (WhOM). The WhOM focuses on ICF constructs of participation and body function. It will be slightly modified to ask users to provide participation goals in the home and community in the context of standing devices/wheelchairs as opposed to wheelchairs alone. The WhOM collects activities that are goals for participation and then has the participant rank the importance and satisfaction with each activity. These rankings allow a quantitative score to be calculated for comparison.
Standing dose - Acceleration data from data loggers will be downloaded and placed on a secure server for further analysis. These data will be visually inspected to determine a threshold for distinguishing sitting and standing postures. These values may vary depending on the mounting on each standing device. After mounting with each system, the participant will go through a sit-to-stand movement and data will be uploaded to ensure the system is detecting movement. This initial movement will also be used to determine an appropriate threshold for standing/sitting. In addition to overall standing time, the investigators will examine frequency of standing bouts and time per standing bout as these are relevant for future pressure injury prevention. The investigators will also monitor movement of the wheelchair during both sitting and standing to understand how often the mobility feature of the MMSW is used during the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Manual Standing Wheelchair
Mobile in seated position; Not mobile in standing position
Manual Standing Wheelchair
Mobile in seated position; Not mobile in standing position
Mobile Manual Standing Wheelchair
Mobile in BOTH seated and standing positions
Mobile Manual Standing Wheelchair
Mobile in BOTH seated and standing positions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Manual Standing Wheelchair
Mobile in seated position; Not mobile in standing position
Mobile Manual Standing Wheelchair
Mobile in BOTH seated and standing positions
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* SCI or stable disorder/dysfunction of the spinal cord
* Tolerates manual wheelchair use on a regular basis
* Sufficient hand \& arm function to operate manual standing wheelchair
* Unable to stand independently without support
* Greater than 6 months post-injury (SCI), or 6 months post diagnosis (disorder/dysfunction)
* Weight less than 125 kg (275 lbs)
* Age 18 or older
* Decisional competency to provide consent and cognitive ability to participate fully in study procedures
* Body size appropriate to fit the devices
* Not involved in another study related to mobility
* Identify an appropriate location for use of the study wheelchair
Exclusion Criteria
* Unhealed lower-limb fractures
* Unstable lower-limb joints
* An active grade 2 or greater pressure injury that can be worsened by standing in the device
* Flap procedure to address pressure injury less than one year earlier
* Not able to propel a manual wheelchair or operate the sit-to-stand mechanism (e.g. weakness, or discomfort)
* Low bone mineral density (BMD), defined by total hip DXA more than 3.5 SD below peak and/or distal femur/proximal tibia BMD below 0.6 g/cm2. (Low BMD at any site will be ineligible).
* Unable to obtain clinically acceptable seating system for study wheelchairs
* Unable to build up standing tolerance within the first eight visits
* Individual deemed not appropriate for participation in the study as determined by study team
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew H Hansen, PhD
Role: PRINCIPAL_INVESTIGATOR
Minneapolis VA Health Care System, Minneapolis, MN
B. Jenny Kiratli, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Palo Alto Health Care System, Palo Alto, CA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, United States
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F3505-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.